We Care – Today and Tomorrow 

When working in SARS-CoV-2-research and vaccine development, reliable results are important. At Eppendorf we want to help you to optimize your results by providing the right equipment and tools.

Now more than ever, it is important to understand the nature of your samples and the likelihood of those samples posing a risk not only to other samples but also to the scientists who are handling them and the wider laboratory.

That scientist is you!

Eppendorf has products designed to speed up results and to protect you:

  • Our centrifuges offer innovative safety features including fixed-angle and swing-bucket rotors with verified aerosol-tightness.
  • Our range of manual pipettes and tips provides ergonomic, safe and accurate liquid handling tools.
  • Our CO2 incubators provide a safe, easy to sterilize environment for your cells.
  • Our range of automated liquid handlers reduces human involvement, speeds up your workflows and improves result accuracy.
  • Our bioprocessing solutions enable rapid progress during vaccine research and development.

In addition, Eppendorf has a variety of  articles and downloadable tools that help you and your laboratory colleagues learn how to work safer to minimize the risk of aerosol contamination in the laboratory.

When growing viral cultures it’s important to reduce the risk of contamination with easy and effective 180 °C high temperature disinfection.

Don´t risk your results! Preventive pipette maintenance, calibration and adjustment services from Eppendorf to ensure reproducible results.

Centrifuges can be a source of bioaerosols, and therefore, it is highly recommended to take adequate precautions.

Are the tools in your lab compliant to the IVD Directive? Do they need to be?

Centrifuges

To support regulatory compliance in EU and EFTA* countries Eppendorf offers not only its manual pipettes and centrifuges in two versions, but also epT.I.P.S.® pipette tips and Eppendorf Tubes®: EU-IVD compliant CE marked versions according to IVD directive 98/79/EC and "General Lab Product" versions for research use. EU-IVD compliant products give peace of mind by supporting your documentation and accreditation requirements where needed.

It is an easy choice, because both versions follow the same extremely high quality standards at Eppendorf. We are not making any compromises when it comes to precision, accuracy, robustness, safety and ergonomics.

*EFTA: Switzerland, Liechtenstein, Norway, Iceland

Find out more


We help defeat COVID-19

Eppendorf has had a clear mission for 75 years: To improve people’s living conditions. The current challenges posed by the corona virus are therefore both a mission and a motivation for us: We support scientists, researchers and diagnosticians around the world in the fight against COVID-19.

To this end, we are concentrating on two main key aspects:
 

  • Ensuring the health of our globally active employees.
  • To provide laboratories with the most modern, innovative equipment and high quality consumables to develop tests to determine whether someone is infected with the corona virus and to search for vaccines and effective drugs against the corona virus.

Our primary goal is to ensure Eppendorf's production and delivery capacity for this purpose, so that the pandemic can be contained quickly and efficiently and the virus combated safely and sustainably.
 

Eppendorf Group-wide Statement on COVID-19 

Business Continuity in Times of COVID-19

A message from your local Eppendorf Sales and Service Organization

I would like to update you on the precautions and actions that Eppendorf is taking due to the rapidly changing situation of the Coronavirus outbreak (COVID-19).

The health and safety of our customers, employees and visitors to our Eppendorf offices is our top priority. We’re also proactively working with our customers and suppliers on how we best manage the situation and mitigate risk. Due to the situation evolving rapidly, we are continuing to monitor it closely. We have established an internal taskforce comprised of members of our Executive team, our Health and Safety experts and other relevant staff who meet regularly and ensure our actions and procedures implemented are timely, adequate and appropriate. The precautions and actions we are taking are in line with the advice provided by state and national governments and World Health Organisation (WHO). We have communicated with our internal employees and advised them of protective hygiene measures as recommended by WHO.

Regarding international exposure, we are also following government advice and have implemented travel restrictions in line with this advice. These restrictions are being monitored daily. We have also taken further measures to limit the exposure of our people to spaces where large groups congregate, and as such have extended our international travel restrictions to include all non- essential domestic travel.

With regards to supply chain disruption, we are monitoring the situation daily with respect to air freight and sea freight and continuity of supply. We will continue to update you on a real-time basis. We have taken the measure to increase our local stock holding significantly to counteract any possible impact and buffer us through the period. We have also put in place contingency plans with our logistics providers to ensure deliveries remain regular.

From a manufacturing perspective we are fortunate that most of our products are made in Europe with little reliance on other parts of the world and currently we are still meeting global demand. We are also revising all open supply agreements to ensure we adhere to the contract, and will advise in advance should this become problematic.

If we are required to close the Eppendorf office, we have contingency plans in place to ensure we minimise any impact on you the customer. We also have, and are continually testing, our business continuity plans to ensure our operations can continue during this time with minimal interruption. In being transparent we expect possible delays and response times as we adapt to new working conditions, but we will minimise and prioritise these as best we can.

There is clearly a great deal of uncertainty for people and organisations to navigate due to the escalating situation with COVID-19. However, what is certain is that in times such as these, collaboration and working together becomes even more important. To that extent I encourage you to keep an open dialogue with your Account Manager, should you have any questions regarding our response to the current pandemic.

Matt Banfield, Managing Director